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Abstract:  Over recent years, several studies have related olive oil ingestion to a low 
incidence of several diseases, including breast cancer. Hydroxytyrosol and tyrosol are two 
of the major phenols present in virgin olive oils. Despite the fact that they have been linked 
to cancer prevention, there is no evidence that clarifies their effect in human breast tumor 
and non-tumor cells. In the present work, we present hydroxytyrosol and tyrosol’s effects 
in human breast cell lines. Our results show that hydroxytyrosol acts as a more efficient 
free radical scavenger than tyrosol, but both fail to affect cell proliferation rates,   
cell cycle profile or cell apoptosis in human mammary epithelial cells (MCF10A) or breast 
cancer cells (MDA-MB-231 and MCF7). We found that hydroxytyrosol decreases the 
intracellular reactive oxygen species (ROS) level in MCF10A cells but not in MCF7 or 
MDA-MB-231 cells while very high amounts of tyrosol is needed to decrease the ROS 
level in MCF10A cells. Interestingly, hydroxytyrosol prevents oxidative DNA damage in 
the three breast cell lines. Therefore, our data suggest that simple phenol hydroxytyrosol 
could contribute to a lower incidence of breast cancer in populations that consume virgin 
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olive oil due to its antioxidant activity and its protection against oxidative DNA damage in 
mammary cells. 
Keywords: breast cancer; Mediterranean diet; olive oil minor compounds; hydroxytyrosol; 
tyrosol; phenols; oxidative stress; reactive oxygen species; DNA damage 
 
1. Introduction 
Olive oil is the major source of fats in the Mediterranean diet and is considered to be responsible for 
the health benefits associated with this diet. In fact, it has been demonstrated that people who consume 
virgin olive oil (VOO) present a lower incidence of several cancers, including breast cancer [1]. This 
effect has previously been attributed to the high content of monounsaturated fatty acids. However, 
more recently, the importance of the minor constituents of olive oil has been considered [2]. Over the 
last five decades, several publications have firmly established that ingestion of small quantities of 
certain compounds isolated from plants can lower the risk of cancer in mammals exposed to 
carcinogens, including polyphenols [3]. 
VOO contains relatively high amounts of minor compounds compared to other oils (refined olive oil 
or seed oils). Among these, phenolic compounds are present at levels between 200 and 1500 mg/kg [4] 
depending on the olive tree variety, climatic and agronomic conditions, degree of maturation at 
harvest, and the manufacturing process [4]. At present, there are many studies reporting biological 
activities in vitro, in vivo and in clinical assays of phenolic compounds naturally present in VOO. 
Between them, anti-inflammatory, cardioprotective antioxidant and chemopreventive effects in breast 
and other types of cancers have been defined [5]. The major phenols identified in olive oils include the 
simple phenols hydroxytyrosol (HT) and tyrosol (TY), secoiridoids and lignans [2]. The concentration 
of TY is always higher than of HT [6]. Hydrolysis of secoiridoid during olive oil storage results in the 
formation of HT and TY [7]. 
It has been well established that HT is a potent antioxidant because of its marked antioxidant 
activity, its ability to scavenge oxygen and nitrogen free radicals, to inhibit Low Density Lipoprotein 
(LDL) oxidation, platelet aggregation and endothelial cell activation and its protection against DNA 
damage [2,8]. HT was able to reduce the synthesis of prostaglandin E2 blocking the transcription of 
COX-2 and 5-lipooxygenase, thereby reducing the chronic influence associated with diseases such as 
cancer [9]. TY has been described as exerting a weak antioxidant activity, although it is able to 
scavenge peroxynitrite and superoxide radicals, inhibit LDL oxidation in Caco2 cells and inhibit   
LPS-induced cytokines release from human monocytes [10,11]. 
It has been suggested that HT and TY compounds might have preventive activity against breast 
cancer, but, at present, the exact role played by these phenols in breast cancer prevention is still 
unknown. In this sense, despite epidemiological evidence, in vitro experiments have not been 
conducted to check if there are different effects of the simple phenols HT and TY between human 
breast cancer cells and human breast non-cancer cells. 
The present study attempts to provide new insights into the antioxidant capacity of HT and TY and 
the in vitro effects on proliferation, cell cycle progression, apoptosis, reactive oxygen species (ROS) Nutrients 2011, 3 
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production and oxidative DNA damage in the human breast epithelial MCF10A cell line and the 
human breast MCF7 and MDA-MB-231 cancer cell lines. 
2. Experimental Section 
2.1. Chemicals and Materials 
The following were purchased from Sigma-Aldrich Co. (St Louis, MO, USA): Hepes Buffer; 
Sodium Pyruvate; Non-Essential Amino Acids mixture 100× (NEAA); 2′,7′-dichlorofluorescein 
diacetate (DCFH-DA); Dimethyl sulfoxide (DMSO); 2,3-Bis(2-methoxy-4-nitro-5-sulfophenyl)-2H-
tetrazolium-5-carboxanilide inner salt (XTT sodium salt) purity ≥90%; N-Methylphenazonium methyl 
sulfate (PMS) purity ~98%; 2-hydroxyphenyl ethanol (Tyrosol, CAS 501-94-0 (TY)) purity 98%;   
DL-all-rac-α-Tocopherol (Vitamin E, CAS 10191-41-0 (TOC)) purity ≥96%; 6-Hydroxy-2,5,7,8-
tetramethylchroman-2-carboxylic acid (Trolox™ CAS 53188-07-1 (TR)) purity ≥97%; 2,2′-Azobis  
(2-methylpropionamidine) dihydrochloride (AAPH) purity ~97%; 2,2-Diphenyl-1-picrylhydrazyl 
(DPPH) purity ~90%, (S)-(+)-camptothecin (CAS 7689-03-4 (CPT)) purity ~95%; 2,2′-azino-bis 
(3-ethylbenzthiazoline-6-sulphonic acid) diammonium salt tablets (CAS 30931-67-0 (ABTS)); PBS; 
HBSS. 2-(3,4-dihydroxyphenyl) ethanol (Hydroxytyrosol, CAS 10597-60-1 (HY)) purity ≥98% was 
obtained from Cayman Chemical (Ann Arbor, MI, USA). Minimum essential medium with Eagle’s 
salts (MEM), Fetal Bovine Serum (FBS) and Phenol-Red-free Roswell Park Memorial Institute 1640 
medium (RPMI) were obtained from PAA Laboratories GmbH (Pasching, Austria). TrypLE Express, 
HuMEC Ready Medium kit and Fluorescein (FL) were obtained from Invitrogen (Eugene, OR, USA). 
K2S2O8 (CAS 7727-21-1) was obtained from Panreac Quimica S.A.U. (Barcelona, Spain). Culture 
plates were obtained from NUNC™ (Roskilde, Denmark). The PI/RNase Staining Buffer kit,   
FITC-conjugated Annexin V and Binding Buffer were obtained from BD Biosciences Pharmigen   
(San Diego, CA, USA). The Comet assay kit was obtained from Trevigen, Inc. (Helgerman CT, 
Gaithersburg, MD, USA).  
2.2. DPPH Assay 
The antioxidant activity of HT and TY against the stable radical DPPH was measured as previously 
reported [12] with some modifications. Briefly, 100 µM ethanolic solution of DPPH was mixed with 
different ethanolic solutions of HT or TY in 96-well plates at 0.06, 0.13, 0.25, 0.5 and 1 (moles of 
antioxidant/moles of DPPH). (±)-α-tocopherol (TOC) was used as a positive control and a sample 
without antioxidant was also measured as a blank control. The decrease in absorbance at 520 nm was 
determined immediately and every 5 min for 2 h in a microplate reader (TECAN, GENios Plus). 
Measurements were performed in triplicate. 
The inhibition of the DPPH radical was calculated according to the following percentage of Radical 
Scavenging Activity (% RSA) formula: 
% RSA = [(AC(0) − AA(t))/AC(0)] × 100 
where AC(0) is the absorbance of the control at t = 0 min and AA(t) is the absorbance of the antioxidant  
at t = 50 min. Nutrients 2011, 3 
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2.3. ABTS Assay 
ABTS cation radical scavenging activity was determined using a previously reported procedure [13]. 
ABTS radicals (ABTS
•+) were obtained by ABTS/H2O 0.5 mM reaction with K2S2O8 for 16 h in the 
dark at room temperature. ABTS
•+ was diluted in ultrapure water until absorbance at 734 nm was  
0.7 (±0.1). HT, TY and Trolox™ (TR) (as antioxidant reference) was dissolved in ethanol to yield a  
10 mM stock solution and diluted with ultrapure water to the assayed concentrations. Twenty 
microliters of each concentration of HT, TY, standard (TR), blank (ultrapure water) or ethanol control 
(8%) were added to a 96-well plate. The reaction was initiated by the addition of 280 µL of ABTS
•+. 
Absorbance readings were taken every 5 min at 30 °C for 2 h in a microplate reader (TECAN, GENios 
Plus). All determinations were carried out in triplicate.  
The inhibition of ABTS
•+ was calculated according to the percentage of Radical Scavenging 
Activity (% RSA) described above (at t = 30 min). 
2.4. ORAC Assay 
Peroxyl radical scavenging activity was measured by the ORACFL assay as previously described [14]. 
A stock solution of HT or TY were reconstituted in DMSO and then diluted in PBS. A stock solution 
of TR, as antioxidant standard, was also diluted in DMSO and diluted in PBS. The assay was carried 
out in 96-well plates with a final volume of 160 μL. Samples were run in triplicate. Fluorescein   
(48 nM) was mixed with various concentrations of SQ, standard (TR) or blank (PBS) containing at 
final volume 1% (v/v) DMSO. Plates were incubated for 15 min at 37 °C. The assay was initiated by 
the addition of AAPH (100 mM) and fluorescence readings (Ex: λ485/Em: λ520 nm) were taken every  
5 min at 37 °C for 160 min in a microplate reader (TECAN GENios Plus). Final results were 
calculated based on the difference in the Area Under the fluorescence decay Curve (AUC) between the 
blank and each sample. The AUC formula was: 
AUC = 1 + f1/f0 + f2/f0 + f3/f0 + f4/f0 + … + f20/f0 
Results were expressed as micromolar TR equivalents (TE) calculated using the line equation from 
the standard curve: 
TE = (Y − b)/m 
where Y is the net AUC (AUCsample − AUCcontrol), m is the slope and b is the Y-intercept. 
2.5. Cell Culture 
Highly invasive MDA-MB-231 human breast cancer cells (estrogen and progesterone receptor-negative), 
minimally invasive MCF7 human breast cancer cells (estrogen and progesterone receptor-positive) and 
immortalized non-tumorigenic MCF10A human breast epithelial cells, were obtained from American 
Type Culture Collection (ATCC, Rockville, MD, USA). Breast tumor cells were grown as a 
monolayer culture in Minimum Essential Medium with Eagle’s salts (MEM) supplemented with   
10% Fetal Bovine Serum (FBS), 1% Hepes Buffer 1 M, 1% Sodium Pyruvate 100 mM and   
1% Non-Essential Amino Acids mixture 100×. MCF10A cells were cultivated in HuMEC Ready 
Medium. All cell lines were maintained at 37 °C in a humidified incubator with 5% CO2. Cells were Nutrients 2011, 3 
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routinely sub-cultured using TrypLE Express solution. Cells in the exponential growth phase were 
used for all experiments. 
2.6. Cell Proliferation Assay 
Cell proliferation, measured as the cellular growth of treated cells vs. untreated controls, was 
measured using an XTT-based assay as described by Scudiero et al. [15] with some modifications. 
Briefly, cells were seeded at 2 × 10
3 cells/well (MCF7) or 1 × 10
3 cells/well (MDA-MB-231 and 
MCF10A) into 96-well culture plates (flat bottom) (100 μL of cell suspension/well). At 24 h after 
plating, 100 μL of fresh culture medium, with different concentrations of HT or TY was added in 
triplicate to the wells. Plates were incubated for 24 h or 24 h followed by a 48 h proliferation period 
with fresh medium at 37 °C and 5% CO2. At these time points, medium was removed and 200 μL of 
fresh RPMI medium without phenol red that contained XTT (200 μg/mL) and PMS (20 μg/mL) was 
added. Plates were incubated for 3 h at 37 °C in 5% CO2 and absorbance was measured at 450 nm 
wavelength (620 nm as reference) in a plate reader (TECAN GENios Plus). Viability was calculated 
using the formula:  
viable cells (%) = (ODtreated cells/ODcontrol) × 100 
where OD is the difference in absorbance between optical density units (OD = OD450 − OD620). 
All measurements were performed in triplicate and each experiment was repeated at least   
three times. 
2.7. Cell Cycle Assay 
Cells were seeded in 12-well culture plates at 1 × 10
5 cells/well for MCF7 and MDA-MB-231 or at 
5 × 10
4 cells/well for MCF10A for 48 h. Cells were then treated with different doses of HT or TY for 
24 h. After incubation, cells were washed in cold PBS, fixed with cold 70% ethanol and stored at  
−20 °C for at least 24 h. At least 1 × 10
4 cells per sample were analyzed on an EPICS XL-MCL 
(Beckman Coulter, Spain) flow cytometer after propidium iodide labeling (PI/RNase Staining Buffer 
kit). The percentage of cells in G0/G1, S and G2/M phases were calculated using FlowJo program 
(v5.7.2). Each experiment was repeated three independent times. 
2.8. Apoptosis 
The percentage of apoptosis was determined using a double staining assay with FITC-conjugated 
Annexin V and propidium iodide (PI). Briefly, after 24 h of cell exposure to the previously indicated 
doses of HT or TY in 12-well culture plates, cells were harvested, washed twice in cold PBS and 
resuspended in 100 μL 1× Annexin Binding Buffer. Cells were then stained with 5 μL Annexin   
V-FITC and 1 μL PI solution, gently vortexed, and incubated for 15 min at room temperature in the 
dark before flow cytometric analysis. As a positive control, cells were treated with 1 μM camptothecin 
(CPT). Each experiment was repeated three independent times. Nutrients 2011, 3 
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2.9. Reactive Oxygen Species Detection 
Intracellular reactive oxygen species (ROS) level was measured using a cell-permeable fluorescent 
probe, 2′,7′-dichlorofluorescein diacetate (DCFH-DA) as we described previously [16]. In brief,   
cells were seeded into 96-well culture plates at 1 × 10
4 cells/well (MCF7, MDA-MB-231 cells) or  
5.5 × 10
3 cells/well (MCF-10A cells). After 24 h at 37 °C and 5% CO2, cells were treated with 
different doses of HT or TY for 24 h. Cells were then washed twice with Hank’s Buffered Salt 
Solution (HBSS) and incubated with fresh DCFH-DA (100 μM) in HBSS for 30 min at 37 °C in 
5% CO2. DCFH-DA stock solution (20.5 mM) was prepared in DMSO and stored at −20 °C for 
maximum one month. After that, cells were washed twice in HBSS, and wells were filled with 100 µL 
HBSS before fluorescence acquisition in a plate reader (TECAN GENios Plus) (Ex: λ485/Em: λ535 nm, 
Gain 60). Intracellular ROS level percentage was calculated as follows:  
F = [(Ft30 − Ft0)/Ft0] × 100 
where Ft0 is the fluorescence at t = 0 min and Ft30 the fluorescence at t = 30 min. 
It has been reported that the addition of H2O2 increases oxidative stress in cultured cells [17]. 
Therefore, in order to evaluate the protective capacity of HT or TY against induced oxidative stress, 
H2O2 (500 μM) was added to the wells after removal of assay medium. This allows avoiding a direct 
reaction in the medium between these compounds and the oxidant source. After 30 min at 37 °C, 
fluorescence was quantified as described above. 
All tests were run in triplicate for each experimental condition and each experiment was repeated at 
least three times. All experiments were conducted using iron-free media (MEM and HuMEC). 
2.10. Alkaline Single-Cell Gel Electrophoresis (Comet Assay) 
At 24 h, cells treated with HT or TY were scraped into 12-well culture plates, washed twice (300× g 
10 min, 4 °C) with cold 1× PBS (Ca
2+/Mg
2+ free) and resuspended in 1 mL of cold 1× PBS. In order to 
evaluate the ability of HT and TY to prevent oxidative DNA damage, cell suspensions were exposed 
for 10 min to 50 µM H2O2 at 4 °C. After that, cells were washed twice and frozen in FBS-DMSO 
(90:10, v/v) at −80 °C until the Comet assay procedure. 
DNA single strand break by alkaline microgel electrophoresis was performed according to   
Singh et al. [18] with some modifications. Cells were thawed in a bath at 37 °C, centrifuged (300× g 
10 min, 4 °C) in cold MEM with 25% FBS and resuspended in cold 1× PBS to a density of   
1.65 × 10
5 cells/mL. Cells were then suspended in melted and cooled (at 40 °C) low melting point 
agarose (LMA). Cell suspensions (50 µL) were spread over a sample area of pre-warmed 1% normal 
melting point agarose (NMA) precoated CometSlide™ slides. After 15 min at 4 °C in the dark, slides 
were immersed in cold Lysis Solution (Trevigen, Inc.) at 4 °C for 30 min to dissolve lipids and proteins. 
In order to separate the two DNA strands, slides were then immersed in fresh Alkaline Solution   
(pH > 13) for 30 min at room temperature in the dark. Electrophoresis was performed in an Ebony 
acrylic electrophoresis tank with a cooled platform containing cold Alkaline Electrophoresis Solution 
(300 mM NaOH, 1 mM EDTA, pH > 13) at 25V (1 V/cm) and 300 mA for 40 min. The slides were 
washed twice with distilled water for 10 min and neutralized with 10 mM Tris-HCl, pH 7.5 for 5 min, Nutrients 2011, 3 
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followed by immersion in 70% ethanol for 5 min and air-dried overnight at room temperature. Slides 
were stained with Sybr
® green before scoring. 
2.11. Slide Scoring and Analysis 
DNA strand breaks were examined using a fluorescence microscope (Zeiss Axiovert 200) equipped 
with a Luca EMCCD camera (Andor Technology, Belfast, UK) under 494 nm excitation and 521 nm 
emission wavelength using the Komet 5.5 software package (Kinetic Imaging Ltd., Liverpool, UK). 
Fifty cell images were randomly characterized per sample using 20× magnification. Relative 
fluorescence between head and tail through the olive tail moment (Olive_TM) was used to determine 
DNA damage. Olive_TM is defined as the product of the Tail Moment Length and the fraction of 
DNA in the tail.  
Olive_TM = [(Tail (mean) − Head (mean)) × Tail (% DNA)]/100 
2.12. Statistical Analysis 
Results are presented as mean (±SEM), except for cell proliferation results. For this assay, results 
are presented as mean (±SD). Results are expressed as a percentage relative to the control, which was 
defined as 100%. Statistical analysis was performed using one-way analysis of variance (ANOVA) 
followed by Fisher’s least significant difference (LSD) test. Values of p  < 0.05 were considered 
significant. Statgraphics Plus 5.1 statistical software (Statpoint Technologies, Inc., Warrenton, VA, USA) 
was used for the statistical analysis. 
3. Results 
3.1. Effect of HT and TY on Radical Scavenging Activity 
Radical scavenging capacity was determined using DPPH, ABTS and ORAC assays. 
The antiradical activity of HT and TY, measured by scavenging activity in the DPPH radical assay, 
indicated that HT at up to 10 mole ratio (mole antioxidant/mole DPPH) exerts a slightly higher 
scavenging activity than TOC while TY does not possess a radical scavenger activity (Table 1(a)). 
The ABTS antiradical assay showed that HT was more effective than TR in scavenging the ABTS 
cationic radical while TY exhibited a maximum 85% RSA at 800 µM (Table 1(b)). 
The peroxyl radical scavenging activity of HT and TY, measured by the ORACFL assay, showed a 
protective effect against AAPH-induced peroxyl radical activity for both phenols. Both exerted higher 
protection against the peroxyl radical than TR for low concentrations up to 100 µM (Table 1(c)). 
3.2. Cell Proliferation 
To investigate the effect of HT and TY on human breast cell growth, cells were treated with 
concentrations of HT or TY ranging from 1 to 100 μM for 24 h. Neither HT nor TY had significant 
effects on the cell proliferation rates of MCF7, MDA-MB-231 and MCF10A cells (Figure 1(a)), even 
after an additional 48 h with fresh medium (Figure 1(b)). We also investigated the potential 
antiproliferative effect of these compounds at high, non-physiological concentrations up to 1000 or Nutrients 2011, 3 
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5000 μM of HT or TY, respectively. HT showed a dose-dependent reduction of cell proliferation in the 
three cell lines from a concentration of 200 μM with an absence of viability observed at 1000 μM, 
while TY did not affect cell viability at any concentration assayed (data not shown). 
No marked changes in cell morphology were observed by light microscopy in any of the cell lines 
tested when concentrations between 1 and 100 μM of HT or TY were used (data not shown). 
Table 1. Antioxidant activity of hydroxytyrosol (HT) or tyrosol (TY) quantified as   
Radical Scavenging Activity (RSA) by (a) DPPH assay (% RSA at 50 min) and (b) ABTS 
assay (% RSA at 30 min); (c) Antioxidant activity quantified as Trolox Equivalent   
(TE) by ORACFL assay. Trolox™ (TR) and α-tocopherol (TOC) were used as   
antioxidant references. 
(a) 
mole AH/ 
mole DPPH 
HT  TY  TOC 
0  3.96 3.64  3.63 
0.06  36.24  n.d.  23.21 
0.13  71.47 5.20  48.16 
0.25  96.40  4.25  75.85 
0.5  97.80 3.02  90.17 
1  98.07  2.59  95.98 
2.5  n.d. 2.34  n.d. 
5  n.d.  3.44  n.d. 
10  n.d. 3.37  n.d. 
n.d.: not determined. 
(b) 
µM  HT  TY  TR 
6  5.07 10.31  n.d. 
12.5  5.45  14.32  n.d. 
25  8.42 20.14  n.d. 
50  18.09  31.81  16.21 
100  36.63 44.55 29.39 
200  69.53  58.25  50.07 
400  96.30 73.82 88.03 
800  99.47  85.04  99.48 
n.d.: not determined. 
(c) 
TE (µM)  HT (µM)  TY (µM) 
3.12  14.82 1.64 
6.25  30.97  8.30 
12.5  50.37 20.84 
25  92.24  58.35 
50  150.43 106.76 
100  262.76  205.57 Nutrients 2011, 3 
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Figure 1. Cell proliferation assay measured with XTT tetrazolium salt (a) after 24 h of HT 
or TY exposure, or (b) after 24 h of HT or TY exposure followed by 48 h with fresh 
medium. Data are the mean (±SD) relative to an untreated control of three independent 
assays carried out in triplicate. 
 
3.3. Cell Cycle and Apoptosis 
To evaluate whether HT or TY interfered with the cell cycle or the induction of apoptosis, MCF7, 
MDA-MB-231 and MCF10A cells were treated for 24 h with increasing concentrations of HT or TY 
(between 10 and 200 μM). The results revealed that HT and TY did not alter the cell cycle in any of 
the cell lines studied (data not shown). 
Flow cytometric analysis of apoptosis revealed that treatment with HT or TY for 24 h did not 
induce apoptosis in MCF10A cells or in MCF7 or MDA-MB-231 cells when compared to the controls 
(data not shown). 
3.4. Intracellular ROS Level 
Intracellular reactive oxygen species (ROS) were quantified by the dichlorofluorescein diacetate 
(DCFH-DA) assay using a microplate reader. Results showed a dose-dependent decrease in ROS level 
of MCF10A cells treated for 24 h with either HT or TY. However, HT and TY failed to significantly 
decrease intracellular ROS level in either MCF7 or MDA-MB-231 cells (Figure 2(a)). While HT 
(a)
(b)Nutrients 2011, 3 
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reduced ROS level by up to 20% in MCF7 cells, this reduction was not considered statistically 
significant (p = 0.34). 
H2O2 effectively induced oxidative stress in both, human breast cancer cells and human breast 
epithelial cells (Figure 2(b)). In order to investigate the in vitro preventive effect of HT or TY against 
H2O2-mediated oxidative stress, we measured the intracellular ROS level in cells treated with HT or 
TY for 24 h. As can be seen in Figure 2(c), MCF10A cells treated with HT or TY showed a significant 
dose-dependent decrease in ROS production compared to the control. In addition, HT was also able to 
decrease the ROS level in MCF7 and MDA-MB-231 cells induced by H2O2 exposure. It is worth 
mentioning that the decrease in ROS level was greater in the breast epithelial cell line than in the 
breast cancer cell lines. On the other hand, TY did not decrease ROS level in MCF7 or   
MDA-MB-231 cells at concentrations up to 5000 μM (Figure 2(c)). 
Figure 2. (a) Intracellular reactive oxygen species (ROS) in breast cells treated for 24 h 
with HT or TY; (b) Increase of the cellular ROS level after an oxidative burn with H2O2; 
(c) Intracellular ROS in breast cells treated for 24 h with HT or TY followed by an 
oxidative burst with H2O2. Inhibitory effects of HT and TY are shown as percent inhibition 
of untreated or H2O2-stimulated fluorescence and represented as the mean ± SEM of three 
independent replicates carried out in triplicate. 
† MCF7; 
‡ MDA-MB-231; * MCF10A 
indicates significant differences. 
 
 
                * 
 * 
*
(b) 
(a) 
 * 
          *       *      *   
                                    *       * 
 * 
           *        *        *   
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Figure 2. Cont. 
 
IC20 and IC50 values were defined as the values for 20% and 50% antioxidant inhibition of basal  
or H2O2-stimulated fluorescence in DCFH-DA probes. The Relative Antioxidant Value (RAV) ratio 
was found to be a good parameter for the determination of oxidative inhibition profiles.  
RAV= [(IC20 (PH)/IC20 (TOC)) + (IC50 (PH)/IC50 (TOC))]/2 
where PH is the compound (simple phenol) and TOC is the reference (α-tocopherol). 
Our results showed that TY has a RAV about 46-fold higher than TOC for MCF10A cells whereas 
HT only has 1.44-fold higher. This indicated much high antioxidant activity of HT compared with TY 
in normal breast cells, but less than TOC (Table 2). In MCF7 and MDA-MB-231 cells, a 50% 
antioxidant inhibition was not observed; therefore, RAV ratios were not determined in these cell lines. 
Interestingly, in H2O2-stimulated MCF10A cells, the RAV ratio of TY was 42-fold higher than 
TOC, indicating a very low antioxidant capacity in normal breast cells. The 0.67-fold difference 
between RAV ratio of HT and TOC is of particular interest, due to the high antioxidant activity of HT 
in H2O2-stimulated MCF10A cells (Table 2). 
Table 2. Oxidative inhibition in MCF10A cells. IC20 and IC50 values defined as the values 
for antioxidant inhibition of basal or H2O2-stimulated fluorescence in DCFH-DA assays and 
the Relative Antioxidant Value (RAV) as a parameter for the relative determination of 
oxidative inhibition profiles compared to α-tocopherol. 
  Basal  H2O2-stimulated 
  HT (µM)  TY (µM)  TOC (µM) HT (µM)  TY (µM)  TOC (µM) 
IC20   3.52  4.04  4.33  2.66  65.36  2.49 
IC50   65.64 2942.60 31.89  20.66 4244.40  73.50 
RAV  1.44  46.60  1.00  0.67  42.00  1.00 
3.5. Effect of HT and TY on Oxidative DNA Damage 
The ability of H2O2 to induce DNA strand breaks in these human breast epithelial cell lines was 
examined using the Comet assay. In untreated cells, DNA does not migrate far from the origin when 
examined by alkaline microgel electrophoresis (Figure 3(a)). Following H2O2 exposure, control and 
(c) 
†          †          †  
‡          ‡          ‡           †          † 
                                     ‡          ‡
*         * 
                     *        * 
                                             * 
           * 
        *      *       * 
                                  * 
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pretreated breast cells with damaged DNA have the shape of a comet, the tail length and fluorescent 
intensity of which are related to the number of DNA strand breaks induced by the DNA-damaging 
agent (Figure 3(b,c)). 
Figure 3. Representative images of Comet assay analysis of MCF10A cells. (a) Untreated 
cell, showing a circular shape indicating absence of DNA damage; (b) 10 min. H2O2 
exposed cell, exhibiting a long and bright tail related to DNA strand breaks, indicating 
DNA oxidative damage; (c) 10 min. H2O2 exposed cell after 24 h of 100 µM HT 
pretreatment, illustrating the reduction of tail length and fluorescent intensity indicative of 
reduced DNA damage. 
 
Breast cells exposed to H2O2 were effectively DNA damaged and the mean olive tail moment 
(Olive_TM) was determined by the Comet assay. Breast epithelial cells were the most sensitive to the 
H2O2-induced DNA damage (Figure 4(a)). 
In unexposed cells, HT reduced DNA damage significantly in MCF7, MDA-MB-231 and MCF10A 
cells whereas TY only reduced it in MCF10A cells (Figure 4(b)). In H2O2-exposed cells, HT showed a 
preventive DNA damage effect in the three cell lines whereas TY was unable to reduce Olive_TM in 
any of the cell lines; indeed, in MDA-MB-231 cells, TY increased Olive_TM significantly. 
Figure 4. Olive Tail Moment (Olive_TM) as the mean ± SEM for three independent 
assays. (a) After an H2O2 injury; (b) after 24 h of HT or TY treatment, and (c) after 24 h of 
HT or TY treatment followed by an H2O2 injury. 
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Figure 4. Cont. 
 
 
4. Discussion 
There is some scientific evidence relating Mediterranean dietary pattern with a lower incidence of 
cardiovascular diseases and cancer, among other diseases. Virgin olive oils (VOOs) represent the main 
source of fats in this diet and it has been demonstrated that consumption of VOOs reduces human 
arterial hypertension, lipid peroxidation of membranes, tumor incidence and number of tumors [19,20]. 
Minor compounds play a key role in VOOs’ healthy properties. Among them, phenols have 
demonstrated healthy bioactivity properties. Interest in phenolic compounds has increased greatly, with 
attention being focused on finding naturally occurring antioxidants for foods or medical uses to replace 
synthetic antioxidants that, in some cases, have been reported to be carcinogenic [21]. 
HT and TY are two of the major simple phenols present in VOOs as simple form or conjugates [2]. 
Bioavailability studies have demonstrated that they are dose-dependently absorbed in animals and  
humans after olive oil ingestion [22], accumulated in the body and, finally, systemically exert 
biological effects [23].  
The present work describes the antioxidant capacity of HT and TY molecules using chemical and 
cellular assays and their relationship with proliferation of human breast tumor vs. normal cells. 
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HT and TY are structurally identical except that HT has an extra –OH group forming a catechol 
group, which is considered responsible for its higher antioxidant activity. This catechol group is able to 
stabilize free radicals through the formation of intermolecular hydrogen bonds [8]. In our chemical 
analysis, the catechol phenol HT exhibited a strong antioxidant activity in DPPH, ABTS and ORAC 
assays, while TY, without a catechol group, showed a weak antioxidant activity in DPPH assay. 
Remarkably, TY acts as an efficient scavenger against ABTS and AAPH radicals, although to a lesser 
extent than HT, indicating the minor importance of the cathecol group in cationic or peroxylic radicals’ 
scavenging activities. These results are in agreement with those previously reported by   
Visioli et al. [8] affirming that HT and, to a lesser degree, TY are more potent scavengers of free 
radicals than vitamin E. 
Although nowadays there is no scientific evidence relating to the physiological concentrations of 
HT or TY after olive oil ingestion, some authors have suggested it could be between 10 and   
100 μM [24]. Cell treatment with HT or TY in the range of their possible physiological concentrations 
(1–100 μM) did not have any effect on cell proliferation in any of the cell lines studied, independently 
of the exposure times. However, HT dramatically reduced the viability of MCF7, MDA-MB-231 and 
MCF10A cell lines when used at concentrations from 200 μM to 1000 μM. Fabiani et al. described 
such an effect in colon adenocarcinoma HT29 cells [25]. Furthermore, HT and TY did not alter the cell 
cycle or induce apoptosis in these cell lines. Although these results are in agreement with those 
achieved in LLC-PK1 renal cells, they are in contrast with results in human promyelocytic leukaemia 
HL60 cells with a noticeable antiproliferative, cell cycle arrest and apoptotic effect of HT. Otherwise, 
TY showed no antiproliferative effect in HL60 cells [7,25]. 
HT or TY’s inability to inhibit breast cancer cell proliferation at the assayed times and 
concentrations, suggests that they cannot protect against breast cancer once developed. Quiles et al. [24] 
described the lack of inhibition of HT or TY in PC3 cells treated with 10 to 250 μM, as did   
Menendez et al. [26] in SKBR3 and MCF7 cells after 5 days of HT or TY treatments in the range of 
6.25 to 100 μM. Moreover, Sirianni et al. [27] recently described the dose-dependent inhibition of 
MCF7 cell proliferation by HT and oleuropein (OL) with treatments of 1 to 100 μM; cell growth was 
induced by 17-β-estradiol (E2). In addition, HT and OL are not able to interfere with estrogen action 
through competition with estrogen receptors (ER), which are responsible for activation of the gene 
expression involved in cell proliferation. 
In order to clarify how nutritional antioxidants are able to prevent or treat oxidative damage,   
Berger [28] affirmed that nutrients cannot treat an installed disease, such as gastrointestinal cancer, but 
that they may prevent its promotion. Indeed, the answer to the question: “Can installed damage caused 
by ROS be treated by antioxidant nutrients?” is “probably not”, but the answer to the question: “Can 
oxidative damage be treated nutritionally?” is “yes” [28].  
Growing evidence supports the hypothesis that risk factors such as lifestyle, age, environment, diet, 
drinking, smoke, etc. are determinants in breast neoplastic transformation, and are closely associated 
with a chronic increase in the basal level of oxidative stress. A decrease in oxidative stress state could 
prevent the development of tumors and, potentially, cancer. In fact, serum markers for oxidative DNA 
damage have been shown to increase in women diagnosed with breast cancer [29]. On the other hand, 
it has been suggested that consumption of VOOs, which are particularly rich in phenolic antioxidants, 
such as HT and TY, should afford considerable protection against breast cancer by inhibiting oxidative Nutrients 2011, 3 
 
 
853
stress [2]. In our study we demonstrated that HT and TY reduce basal and H2O2-induced ROS level in 
breast epithelial MCF10A cells, whereas TY failed to reduce both in MCF7 or MDA-MB-231 cells 
and HT only reduced H2O2-induced ROS level slightly in breast cancer cells. These results point to a 
differential antioxidant activity of both compounds between normal breast and tumor cells as we 
described for squalene [16]. Thus, we suggest that HT and TY could prevent oxidative stress in normal 
breast cells, thereby preventing the initiation of a chain of reactions to transform normal cells into 
cancer cells. Noticeably, it is necessary to use a much larger amount of TY to obtain the same ROS 
reduction level as HT in MCF10A cells (Table 2). Up to 100 μM concentrations of HT and TY used in 
the present study are probably within the physiological range. However, 500 to 5000 μM of TY exceed 
this range and could be regarded as being in the pharmacological range. 
Di Bendeto et al. [11] described differences between HT and TY in inhibiting cell-mediated 
oxidation of LDL (100% HT vs. 40% TY) in J774 A.1 macrophage cells due to its intracellular 
presence. Thus, time-dependent TY, accumulated inside the cell was effective only at later time-points 
(24 h) or at higher concentrations than HT, which was rapidly found inside the cells and disappeared 
within 18 h. Thus, we can presume a quick antioxidant defense by HT followed by a slower defense by 
TY upon VOO intake. 
Estrogens, known human breast pro-carcinogens, exert their actions by two mechanisms;   
the ER-dependent mechanism, involving the activation of ER and subsequent stimulation of cell 
growth and proliferation [30] or the ER-independent mechanism, involving the generation of genotoxic 
estrogen metabolites, which are highly reactive and damage DNA by the formation of free radicals and 
consequently ROS [30]. In accordance with Sirianni et al. [27], HT inhibition of E2-induced MCF7 
proliferation does not involve the ER-dependent mechanism but points to an inhibition of the E2 
signaling pathway. Felty et al. [31] identified mitochondria as a major source of E2-induced ROS 
(mtROS) in breast cancer cells and described mtROS as a messenger involved in signaling pathways of 
cell proliferation control, increasing the transcription of cell cycle genes. These authors found the same 
amount of mtROS in ER-negative MDA-MB-468 cells and in ER-positive MCF7 or T47D cells, 
suggesting that mtROS production does not depend on the presence of ER in breast cancer cells. If 
mtROS acts as a messenger in breast cancer proliferation, it could explain why an antioxidant such as 
HT reduces E2-induced cell proliferation, as described by Sirianni et al., whereas in the same 
concentrations without E2 stimulation we do not detect any significant growth alteration. 
Cellular protection against oxidative stress is provided by two types of antioxidants; direct 
antioxidants with a redox activity; and indirect antioxidants (redox active or not) which activated the 
Nrf2/ARE pathway resulting in transcription of phase II enzymes such as glutathione S-transferase, 
NAD(P)H: quinone oxidoreductase 1 or glutathione reductase [32]. In addition to the fact that HT and 
TY act as direct antioxidants, they could also be indirect antioxidants activating the nuclear   
factor-like 2 (Nrf2). Nrf2, considered a key factor in the cellular defense mechanisms against oxidative 
stress, might be induced more strongly in MCF10A cells than in MCF7 and might have little or no 
effect in MDA-MB-231 cells, explaining the differential protection effect of HT and TY on 
intracellular ROS level. To the best of our knowledge, until now, only Liu et al. [33] have described 
the protection of HT on ARPE-19 human retinal pigment epithelial cell line from oxidative stress 
induced by acrolein, a major component of cigarette smoke. Further studies will be necessary to Nutrients 2011, 3 
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elucidate the possible Nrf2/ARE pathway intervention of HT and TY differential antioxidant activity 
in breast cell lines. 
HT has been described as preventing DNA damage beyond its antioxidant capacity, as it can affect 
a range of enzymes, including cyclooxygenase and NAD(P)H oxidase while TY has no protective 
effect [8]. In accordance with these authors, our findings point to a protective effect of HT against 
basal and H2O2-induced DNA damage regardless of the breast cellular type, whereas TY only has a 
protective effect on ROS basal level in non-tumoral breast cells. 
Both compounds reduce intracellular ROS level and oxidative DNA damage in normal breast cells. 
This could protect against cellular mutations, preventing carcinogenesis. However, when the disease 
has occurred, oxidative status in the malignancy place is altered. In this condition, while HT still 
protects non-tumor breast cells against DNA damage, TY fails to protect them at physiological 
concentrations. Although HT contributes to reduce DNA damage in normal breast cells, it protects 
breast tumor cells too. Accordingly, our results must be interpreted carefully, because a reduction of 
DNA damage in cancer cells might promote cell growth and might inhibit the action of anthracycline 
chemotherapeutic agents, such as doxorubicin, which induces apoptosis of cancer cells by the 
oxidative damage resulting from enhanced oxidative state of the cells or, in contrast, might reduce 
ROS messenger signaling of proliferation resulting in a reduction of tumor cell growth. In any case, we 
have not detected any modulation of the growth activity in vitro in breast cancer cells after HT or TY 
treatment at the assayed times.  
In this paper, HT has been described as an antioxidant compound with higher activity than TY and 
related to the prevention of breast cancer, but we must not forget that VOO´s minor compounds can 
interact with each other, potentiating or inhibiting the effects described for each component alone. Our 
results indicate some healthy properties of these two simple phenols which may be of interest in 
pharmacology or as a nutritional supplement or could even lead to establishing the ideal concentrations 
of each component in VOOs in order to label it as a healthy oil. However, we must be prudent about 
extrapolating these results regarding epidemiological olive oil health impacts. Future work is needed to 
investigate these synergetic or inhibitory effects. 
5. Conclusions 
The simple phenol HT could contribute to the preventive cancer activity attributed to VOOs due to 
the reduction of oxidative stress and oxidative DNA protection in normal breast cells at physiological 
concentrations, whereas TY is needed at pharmacological concentrations to reduce oxidative stress and 
fails to protect DNA damage against an oxidative burst. 
Both phenols exert a selective antioxidant defense, preventing oxidation in normal breast cells but 
not in breast cancer cells, which could be helpful to cancer therapies that increase oxidative stress. HT 
also prevents induced DNA damage in cancer cells, so it might interfere with these therapies. 
Although in vitro studies have pointed to a preventive role of HT against human breast cancer, the 
precise mechanisms of action remain to be clarified. Further studies are necessary to elucidate the 
cellular signaling events that HT and TY target in oxidative
 stress protection and subsequent breast 
cancer prevention. Nutrients 2011, 3 
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